Clinical trials: Excretion
End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn, Neonatal Jaundice
End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis
The purpose of this study is to evaluate if adding a noninvasive testing of End Tidal Carbon Monoxide with a FDA approved device will help improve management of jaundice in the Neonates by reducing the number of lab draws, Coombs…
- Conditions
- End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn, Neonatal Jaundice, End Tidal Carbon Monoxide
- Trial name
- NCT05475223
- Testing
- End Tidal Carbon Monoxide Value
- Volunteers
- 350 people, healthy volunteers welcome
- Sponsor
- Cedars-Sinai Medical Center
Urinary Sodium Excretion, Salt Intakes
Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Population
The accurate evaluation of daily salt or sodium intake is difficult to implement in clinical practice and large epidemiological studies.
- Trial name
- NCT03204422
- Testing
- No intervention
- Where
- China
- Volunteers
- 330 people, healthy volunteers welcome
- Sponsor
- Beijing Children's Hospital